views: 28

Yuanyuan Zhao(赵媛媛)

.Department of Internal Medicine,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Guangzhou ,China

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers70 papers

Sort

By YearBy Citation

The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort study.

Yuxiang Ma, Shuang Xin, Qingguang Lin, Wei Zhuang,Yuanyuan Zhao,Xia Zhu,Hongyun Zhao,Min Huang, Xu Xun,Yunpeng Yang,Wenfeng Fang,Li Zhang

Annals of translational medicine, no. 24 (2019): 806-806

WOSBibtex

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis.

Zhonghan Zhang, Kangmei Zeng, Shen Zhao,Yuanyuan Zhao,Xue Hou, Fan Luo, Feiteng Lu,Yaxiong Zhang,Ting Zhou,Yuxiang Ma,Yunpeng Yang,Wenfeng Fang

Therapeutic advances in medical oncology, (2019): 1758835919891652

WOSBibtex

Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis.

Zhonghan Zhang,Yuanyuan Zhao, Feiteng Lu,Xue Hou,Yuxiang Ma, Fan Luo, Kangmei Zeng, Shen Zhao,Yaxiong Zhang,Ting Zhou,Yunpeng Yang,Wenfeng Fang

Annals of translational medicine, no. 18 (2019): 452-452

WOSBibtex

Polymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients.

Shuang Xin,Yuanyuan Zhao, Changzheng Wang,Yan Huang, Wei Zhuang,Yuxiang Ma,Min Huang, Xun Xu,Xueding Wang,Li Zhang

The pharmacogenomics journal, pp.1-9, (2019)

WOSBibtex

A multicenter, randomized, double-blind, placebo-controlled phase III study of anlotinib or placebo in combination with gemcitabine and cisplatin (GP) as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (R/M NPC).

Yunpeng Yang,Yan Huang,Wenfeng Fang,Yuxiang Ma, Qingqing Cai,Zhi-Ming Li,Hongyun Zhao,Yuanyuan Zhao,Ting Zhou,Shaodong Hong,Yaxiong Zhang,Li Zhang

Journal of Clinical Oncology, (2019)

Bibtex

Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.

Yan Huang,Ying Tian,Yuanyuan Zhao,Cong Xue,Jianhua Zhan, Lin Liu,Xiaobo He,Li Zhang

Cancer communications (London, England), no. 1 (2018): 15

WOSBibtex

Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis.

Zhonghan Zhang,Yaxiong Zhang,Gang Chen,Shaodong Hong,Yunpeng Yang,Wenfeng Fang, Fan Luo, Xi Chen,Yuxiang Ma,Yuanyuan Zhao,Jianhua Zhan,Cong Xue

The oncologist, (2018)

WOSBibtex

p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells.

Xue Hou, Run Gong,Jianhua Zhan,Ting Zhou,Yuxiang Ma,Yuanyuan Zhao,Yaxiong Zhang,Gang Chen, Zhonghan Zhang, Shuxiang Ma,Xi Chen, Fangfang Gao

BMC cancer, no. 1 (2018): 641

WOSBibtex

Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database: Survival impact of prior cancer history for patients

Huaqiang Zhou,Yan Huang, Zeting Qiu,Hongyun Zhao,Wenfeng Fang,Yunpeng Yang,Yuanyuan Zhao,Xue Hou,Yuxiang Ma,Shaodong Hong, Ting Zhou,Yaxiong Zhang

International Journal of Cancer, no. 7 (2018): 1569-1577

Cited by2Bibtex

Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.

Shen Zhao,Ting Zhou, Shuxiang Ma,Yuanyuan Zhao,Jianhua Zhan,Wenfeng Fang,Yunpeng Yang,Xue Hou, Zhonghan Zhang,Gang Chen,Yaxiong Zhang,Yan Huang

Cancer medicine, (2018)

WOSBibtex

Impact of Prior Cancer History on the Overall Survival of Patients Newly Diagnosed with Cancer: A Pan-cancer Analysis of the SEER Database.

Huaqiang Zhou,Yan Huang, Zeting Qiu,Hongyun Zhao,Wenfeng Fang, Yunpeng Yang,Yuanyuan Zhao, Xue Hou,Yuxiang Ma, Shaodong Hong, Ting Zhou, Yaxiong Zhang

International journal of cancer, (2018)

WOSBibtex

Optimal prophylaxis of chemotherapy-induced nausea and vomiting for moderately emetogenic chemotherapy: a meta-analysis.

Yaxiong Zhang,Xue Hou,Rong Zhang,Gang Chen,Yan Huang,Yunpeng Yang,Yuanyuan Zhao,Wenfeng Fang,Shaodong Hong,Shiyang Kang,Ting Zhou, Zhonghan Zhang

Future oncology (London, England), (2018)

WOSBibtex

The efficacy of first-line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis.

Shu-Xiang Ma,Ting Zhou,Yan Huang,Yun-Peng Yang,Jian-Hua Zhan,Ya-Xiong Zhang, Zhong-Han Zhang,Yuan-Yuan Zhao,Wen-Feng Fang,Yu-Xiang Ma,Li-Kun Chen,Hong-Yun Zhao

Annals of translational medicine, no. 11 (2018): 201

WOSBibtex

The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer.

Ning-Ning Zhou,Yuan-Yuan Zhao,Lin-Zhu Zhai,Chao-Mei Ruan,Yun-Peng Yang,Yan Huang,Xue Hou,Li-Kun Chen,Ting Zhou,Li Zhang

Journal of Cancer, no. 13 (2018): 2232-2236

Cited by1WOSBibtex

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.

Wenfeng Fang,Yunpeng Yang,Yuxiang Ma,Shaodong Hong, Lizhu Lin, Xiaohui He,Jianping Xiong, Ping Li,Hongyun Zhao,Yan Huang,Yang Zhang,Likun Chen

The Lancet. Oncology, (2018)

Cited by5WOSBibtex

Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma.

Yuan-Yuan Zhao,Ying Tian, Lin Liu,Jian-Hua Zhan,Xue Hou,Xi Chen,Ting Zhou,Yan Huang,Li Zhang

Drug design, development and therapy, (2018): 2655-2663

WOSBibtex

P038 Docosapentaenoic Acid and Lung Cancer Risk: A Mendelian Randomisation Study

J. Liu,H. Zhou,Y. Zhang,Y. Huang,W. Fang,Y. Yang,S. Hong,G. Chen,S. Zhao,X. Chen,Z. Zhang,J. Shen

Journal of Thoracic Oncology, no. 12 (2018)

Bibtex

Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.

Jin Sheng,Ya-Xiong Zhang,Xiao-Bo He,Wen-Feng Fang,Yun-Peng Yang, Gui-Nan Lin, Xuan Wu, Ning Li, Jing Zhang, Lin-Zhu Zhai,Yuan-Yuan Zhao,Yan Huang

The oncologist, no. 1 (2017): 53-60

Cited by1WOSBibtex

The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer.

Yaxiong Zhang,Gang Chen, Xi Chen,Wenfeng Fang, Fei Gao,Yunpeng Yang,Yuanyuan Zhao,Yuxiang Ma,Shaodong Hong, Zhonghan Zhang, Siyu Miao, Manli Wu

Journal of Cancer, no. 10 (2017): 1865-1871

Cited by3WOSBibtex

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-based Subtypes.

Li Zhang, Kenzie D MacIsaac, Ting Zhou,Pei-Yu Huang, Chunlin Xin, Jason R Dobson, Kun Yu, Derek Y Chiang, Yue Fan, Marc Pelletier, Yan Wang, Savina Jaeger

Molecular cancer research : MCR, (2017)

Cited by7WOSBibtex

View All

Base Info Papers Patents Projects